DWS
Dynamic Wealth Strategies Portfolio holdings
AUM
$139M
1-Year Return
11.21%
This Quarter Return
+0.94%
1 Year Return
+11.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
+$7.92M
(+7.1%)
Cap. Flow
+$7.58M
Cap. Flow
% of AUM
6.3%
Top 10 Holdings %
Top 10 Hldgs %
56.85%
Holding
234
New
169
Increased
31
Reduced
28
Closed
–
Top Buys
| 1 |
iShares MSCI United Kingdom ETF
EWU
|
$1.16M |
| 2 |
Vanguard Mid-Cap ETF
VO
|
$921K |
| 3 |
iShares MSCI Japan ETF
EWJ
|
$411K |
| 4 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$402K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$212K |
Top Sells
| 1 |
Invesco S&P 500 Quality ETF
SPHQ
|
$2.23M |
| 2 |
iShares US Small Cap Equity Factor ETF
SMLF
|
$1.18M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
$361K |
| 4 |
Vanguard Value ETF
VTV
|
$352K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$323K |
Sector Composition
| 1 | Technology | 3.39% |
| 2 | Financials | 1.85% |
| 3 | Healthcare | 1.56% |
| 4 | Consumer Discretionary | 1.29% |
| 5 | Communication Services | 1.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
ARK Genomic Revolution ETF
ARKG
$1.05B
| $7.79K | 0.01% |
+375
| New | +$7.79K |
|
202
Intuitive Surgical
ISRG
$163B
| $7.43K | 0.01% |
+15
| New | +$7.43K |
|
203
CVS Health
CVS
$93.5B
| $7.39K | 0.01% |
+109
| New | +$7.39K |
|
204
Incyte
INCY
$16.7B
| $7.08K | 0.01% |
+117
| New | +$7.08K |
|
205
Cardinal Health
CAH
$35.7B
| $6.75K | 0.01% |
+49
| New | +$6.75K |
|
206
Carnival Corp
CCL
$43.1B
| $5.86K | ﹤0.01% |
+300
| New | +$5.86K |
|
207
Exelixis
EXEL
$10.1B
| $5.21K | ﹤0.01% |
+141
| New | +$5.21K |
|
208
Natera
NTRA
$22.9B
| $5.09K | ﹤0.01% |
+36
| New | +$5.09K |
|
209
Guardant Health
GH
$7.65B
| $5.07K | ﹤0.01% |
+119
| New | +$5.07K |
|
210
Intel
INTC
$108B
| $5K | ﹤0.01% |
+220
| New | +$5K |
|
211
Dow Inc
DOW
$16.9B
| $4.96K | ﹤0.01% |
+142
| New | +$4.96K |
|
212
Exact Sciences
EXAS
$9.73B
| $4.85K | ﹤0.01% |
+112
| New | +$4.85K |
|
213
Phinia Inc
PHIN
$2.28B
| $4.8K | ﹤0.01% |
+113
| New | +$4.8K |
|
214
Illumina
ILMN
$15.5B
| $4.6K | ﹤0.01% |
+58
| New | +$4.6K |
|
215
Biogen
BIIB
$20.5B
| $4.52K | ﹤0.01% |
+33
| New | +$4.52K |
|
216
Sangamo Therapeutics
SGMO
$160M
| $3.67K | ﹤0.01% |
+5,600
| New | +$3.67K |
|
217
Warner Bros
WBD
$29.1B
| $3.54K | ﹤0.01% |
+330
| New | +$3.54K |
|
218
Cytokinetics
CYTK
$5.95B
| $2.73K | ﹤0.01% |
+68
| New | +$2.73K |
|
219
iShares Core US Aggregate Bond ETF
AGG
$131B
| $2.59K | ﹤0.01% |
+26
| New | +$2.59K |
|
|
MRP
220
Millrose Properties, Inc.
MRP
$5.68B
| $2.47K | ﹤0.01% |
+93
| New | +$2.47K |
|
221
Myriad Genetics
MYGN
$632M
| $2.45K | ﹤0.01% |
+276
| New | +$2.45K |
|
222
Ionis Pharmaceuticals
IONS
$9.46B
| $2.41K | ﹤0.01% |
+80
| New | +$2.41K |
|
223
Acadia Pharmaceuticals
ACAD
$4.3B
| $2.18K | ﹤0.01% |
+131
| New | +$2.18K |
|
224
Pacific Biosciences
PACB
$372M
| $1.98K | ﹤0.01% |
+1,678
| New | +$1.98K |
|
225
Maravai LifeSciences
MRVI
$341M
| $1.79K | ﹤0.01% |
+808
| New | +$1.79K |
|